VC-backed TScan Therapeutics raises $100m for IPO

TScan Therapeutics, a biopharmaceutical company, has raised about $100 million for its IPO after pricing its over 6.6 million shares at $15 per share.

16 July 2021•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail